HDAX Therapeutics
Developer of small molecule therapeutics intended for the treatment of HDAC6-driven pathologies such as neuropathies and cardiometabolic diseases. The company focuses on creating a targeted therapeuti...
Valuation
$0
Share Price
N/A
Total Raised
$5.9M
Last Round
N/A